Investors / Discovery Capital (University of Minnesota)
Discovery Capital (University of Minnesota)
Discovery Capital (University of Minnesota) is an university or institute fund based in the United States. Discovery Capital (University of Minnesota) has backed 1 Canadian AI company in the Index, joining 1 tracked round. The most recent was RetiSpec's US$10M Series A in July 2024. Discovery Capital (University of Minnesota) most often invests alongside Alzheimer's Drug Discovery Foundation Diagnostics Accelerator, Centre for Aging + Brain Health Innovation and Eli Lilly and Company.
University/Institute based in US. 1 Canadian AI company in the Index, 1 tracked round.
- Type
- University/
Institute - HQ country
- US
- Companies
- 1
- Tracked rounds
- 1
- Led
- 0
- First tracked deal
- RetiSpec, Jul 2024
- Latest tracked deal
- RetiSpec, Jul 2024
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| RetiSpec | Series A · Jul 2024 · US$10M round | US$10M | — |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Alzheimer's Drug Discovery Foundation Diagnostics Accelerator (1 shared round), Centre for Aging + Brain Health Innovation (1 shared round), Eli Lilly and Company (1 shared round), Gentex Corporation (1 shared round), iGan Partners (1 shared round), Ontario Brain Institute (1 shared round), Topcon Healthcare (1 shared round), Verge HealthTech Fund (1 shared round)
Data as of November 10, 2026.